Ketan Buch

697 total citations
8 papers, 110 citations indexed

About

Ketan Buch is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ketan Buch has authored 8 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Infectious Diseases and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ketan Buch's work include Pulmonary Hypertension Research and Treatments (2 papers), Mycobacterium research and diagnosis (1 paper) and Food Allergy and Anaphylaxis Research (1 paper). Ketan Buch is often cited by papers focused on Pulmonary Hypertension Research and Treatments (2 papers), Mycobacterium research and diagnosis (1 paper) and Food Allergy and Anaphylaxis Research (1 paper). Ketan Buch collaborates with scholars based in United States, Belgium and United Kingdom. Ketan Buch's co-authors include Krishna Thavarajah, Rayid Abdulqawi, Yoshikazu Inoue, Jeffrey J. Swigris, Daniel F. Dilling, Dirk Koschel, Angel Coz Yataco, Rade Tomic, Kevin K. Brown and Barbara Phillips and has published in prestigious journals such as Critical Care Medicine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Ketan Buch

7 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ketan Buch United States 5 82 36 17 16 13 8 110
Damian Korzybski Poland 6 78 1.0× 67 1.9× 5 0.3× 22 1.4× 11 0.8× 16 122
Lizzie Grillo United Kingdom 6 118 1.4× 49 1.4× 8 0.5× 13 0.8× 3 0.2× 12 137
Joshua Sill United States 7 94 1.1× 50 1.4× 10 0.6× 9 0.6× 6 0.5× 30 179
Giovanni Bona Switzerland 5 33 0.4× 11 0.3× 5 0.3× 6 0.4× 12 0.9× 14 67
Andrew L. Banyai 6 50 0.6× 15 0.4× 11 0.6× 18 1.1× 14 1.1× 45 142
Daniel Van Handel United States 3 28 0.3× 40 1.1× 8 0.5× 12 0.8× 17 1.3× 9 209
Annachiara Cavaliere Italy 7 51 0.6× 29 0.8× 46 2.7× 28 1.8× 21 1.6× 15 142
Rahul J. Thomas Australia 7 39 0.5× 19 0.5× 17 1.1× 9 0.7× 19 97
Ioannis Pneumatikos Greece 5 17 0.2× 9 0.3× 16 0.9× 38 2.4× 5 0.4× 7 98
Yoshihisa Nagayama Japan 6 16 0.2× 9 0.3× 5 0.3× 26 1.6× 9 0.7× 7 82

Countries citing papers authored by Ketan Buch

Since Specialization
Citations

This map shows the geographic impact of Ketan Buch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketan Buch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketan Buch more than expected).

Fields of papers citing papers by Ketan Buch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketan Buch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketan Buch. The network helps show where Ketan Buch may publish in the future.

Co-authorship network of co-authors of Ketan Buch

This figure shows the co-authorship network connecting the top 25 collaborators of Ketan Buch. A scholar is included among the top collaborators of Ketan Buch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketan Buch. Ketan Buch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bajwa, Ednan K., Amit Kumar, E. J. Messina, et al.. (2024). Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 19. 1105–1121. 5 indexed citations
2.
Buch, Ketan, et al.. (2022). 405: A CASE OF CMV POLYRADICULOMYELITIS IN AN IMMUNOCOMPETENT PATIENT. Critical Care Medicine. 51(1). 189–189.
3.
Swigris, Jeffrey J., Kevin K. Brown, Rayid Abdulqawi, et al.. (2018). Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. European Respiratory Review. 27(150). 180075–180075. 50 indexed citations
4.
Yataco, Angel Coz, et al.. (2015). Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure. Heart Failure Reviews. 21(3). 323–346. 23 indexed citations
5.
Flannery, Alexander H., et al.. (2015). Eosinophilia and Fever with Levetiracetam: A Case Report. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(8). e131–5. 3 indexed citations
6.
Thornton, Alice, et al.. (2014). Fulminant Invasive Pulmonary Aspergillosis After a Near-Drowning Accident in an Immunocompetent Patient. Annals of Pharmacotherapy. 48(9). 1225–1229. 12 indexed citations
7.
Ofotokun, Ighovwerha, et al.. (2004). Pulmonary Mycobacterium avium Complex Infection in HIV-Infected Patient After Immune Reconstitution With Highly Active Antiretroviral Therapy. Infectious Diseases in Clinical Practice. 12(3). 171–173. 1 indexed citations
8.
Anstead, Michael, Barbara Phillips, & Ketan Buch. (1998). Tolerance and intolerance to continuous positive airway pressure. Current Opinion in Pulmonary Medicine. 4(6). 351–354. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026